Fundraising Fox
Rev Genomics
YC S17San Francisco, US · Founded 2016 · California corporation · 8 employees · Hiring · 10 known investors
Find your way into Rev Genomics
Sign up to see every warm intro you have to Rev Genomics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Rev Genomics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Rev Genomics uses genomic selection, tissue culture, and molecular analysis to develop high-value crop cultivars for breeders and seed banks. The company creates novel plant phenotypes and provides molecular fingerprinting and breeding technology primarily for specialty crops in California.
Also known as Inc.
Founders & leadership· Y Combinator alumni (S17)
Rev Genomics was founded in 2016 by Bertrand Vick and Robert John Markelz.
BV
Bertrand VickCo-founder · CEOBertrand Vick is the founder and CEO of Rev Genomics, which develops high-value crop cultivars for breeders and seed banks using genomic selection and molecular analysis. He previously founded and served as Chief Scientific Officer of Aurora Algae Inc., bringing expertise in molecular genetics, strain development, and biotechnology operations.
RJ
Robert John MarkelzCo-founder
GE
Gloria E WebsterNamed on SEC filing
RM
Robert MarkelzVice President of Genomicsformer
Investors · 10
Y Combinator✓ confirmed by Rev GenomicsSan Francisco · $500K
How we know: the Y Combinator directory · open dataset · 5k.vc investor directory · Not right? Tell us
AdditionreportedNew York
How we know: Y Combinator's founder network · Not right? Tell us
Agrolimen Venturesreported
How we know: Y Combinator's founder network · Not right? Tell us
Floret VenturesreportedSan Francisco
How we know: Y Combinator's founder network · Not right? Tell us
Gron Ventures, LlcreportedNewport Beach
How we know: Y Combinator's founder network · Not right? Tell us
L4 Inc.reportedToronto
How we know: Y Combinator's founder network · Not right? Tell us
MicroVenturesreportedAustin
How we know: Y Combinator's founder network · Not right? Tell us
S2 CapitalreportedSan Francisco
How we know: Y Combinator's founder network · Not right? Tell us
Venture Investment AssociatesreportedPeapack
How we know: Y Combinator's founder network · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$1.5M disclosed across 1 round · 2019
▶$1.5MraisedMay 2019 · 36 investors · BiotechnologyRule 506(c)
▶$1.5MraisedMay 2019 · 36 investors · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- Bertrand VickExecutive Officer, Director, Promoter
- Robert John MarkelzExecutive Officer, Director, Promoter
- Gloria E WebsterDirector, Promoter
- James Edward LongPromoter
- Offering amount
- $2M
- Amount sold
- $1.5M
- Minimum investment
- $5K
- Proceeds to insiders
- $50K
- First sale
- Apr 2019
- Incorporated
- Corporation, California, 2016
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 10
BeauBeau automates data extraction and organization from client files, delivering structured data in formats like filled PDFs, CRM integrations, and spreadsheets. The service eliminates manual data entry for businesses that collect client information through forms.
FlowEQFlowEQ is a no-code workflow automation platform that embeds within existing business systems to automate recurring processes and support customer service, quality tracking, and member services operations. It provides integrations with 100+ business applications including CRMs, fulfillment systems, and e-signature platforms.
RevlRevl develops AI-powered video capture and editing technology that automatically creates cinematic videos in real-time for experiential activities. The company targets the experience economy market, including adventure sports, cruises, and similar attractions.
Polaris GenomicsPolaris Genomics is a Veteran-owned biotech startup mapping molecular biomarkers to develop objective, biologically-based diagnostics and novel therapeutics for mental health and neuropsychiatric conditions such as PTSD. It combines genomics and AI to advance precision mental health care.
flukeFluke is a Brazilian mobile carrier that leases network infrastructure from incumbents and offers customers flexible, customized plan options instead of fixed data packages. The company targets dissatisfied users of traditional carriers.
VerinomicsVerinomics develops crop improvement technology by combining genomics, computational biology, and a transgene-free gene editing platform, with an AI-driven population genomics tool to identify high-value trait genes. It serves breeding programs, agricultural businesses, and research institutions focused on specialty and vegetatively propagated crops such as leafy greens.
Phase GenomicsPhase Genomics develops long-range genome sequencing technology based on proximity ligation, along with computational tools, for scientists studying cancer, inherited diseases, microbiomes, and biodiversity. It serves academic and research institutions and biopharmaceutical firms across life sciences, medicine, and agriculture.
RevvityRevvity develops and sells reagents, instruments, software, and services for life sciences research and clinical diagnostics, serving pharmaceutical, biotech, academic and government institutions across drug discovery, development, and disease diagnosis workflows.
Orbit GenomicsOrbit Genomics is a precision healthcare company built on OrbiSeq, an AI-enabled genomics platform that analyzes short tandem repeats (STRs) alongside single nucleotide polymorphisms to detect disease biology. Its lead product is a blood test for diagnosing early-stage lung cancer in patients with indeterminate pulmonary nodules, with a pipeline extending across other therapeutic areas.
10x Genomics10x Genomics offers single cell analysis technology, including its Flex assay and Flex Apex product, which use probe-based chemistry and plate-based multiplexing to profile fresh, frozen, and FFPE samples for researchers. The tools support applications in cancer, immunology, and neuroscience, enabling gene expression and multiomic profiling of cell surface protein, intracellular protein, and CRISPR guides.
Companies working in the same space as Rev Genomics.
Legal entities · 1
corporate structureRev Genomics, Inc.
Frequently asked questions
- What does Rev Genomics do?
- Rev Genomics uses genomic selection, tissue culture, and molecular analysis to develop high-value crop cultivars for breeders and seed banks. The company creates novel plant phenotypes and provides molecular fingerprinting and breeding technology primarily for specialty crops in California.
- Who founded Rev Genomics?
- Rev Genomics was founded by Bertrand Vick, Robert John Markelz in 2016.
- Who are Rev Genomics's investors?
- Rev Genomics's investors include Y Combinator, Merida Capital Holdings, Addition, Agrolimen Ventures, Floret Ventures, Gron Ventures, Llc, L4 Inc., MicroVentures and 2 more.
- How much funding has Rev Genomics raised?
- Rev Genomics has disclosed $1.5M raised across 1 round.
- Where is Rev Genomics headquartered?
- Rev Genomics is headquartered in San Francisco, US.